AG-825

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameAG-825
Drug Alias NameAG-825
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Yang-Ming University, Kaohsiung, Taiwan, Roc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Yang-Ming University, Kaohsiung, Taiwan, Roc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A